SCHEMBL23520060

SCHEMBL23520060

C1CC2CN(CC3CCNCC3)CC2C1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GBA1 P04062 5/20 0.50
SCN1A P35498 1/20 0.42
SCN4A P35499 1/20 0.42
SCN7A Q01118 1/20 0.42
KCNH2 Q12809 1/20 0.42
SCN5A Q14524 1/20 0.42
SCN9A Q15858 1/20 0.42
SCN2A Q99250 1/20 0.42
SCN3A Q9NY46 1/20 0.42
SCN11A Q9UI33 1/20 0.42
SCN8A Q9UQD0 1/20 0.42
SCN10A Q9Y5Y9 1/20 0.42
CHRM5 P08912 1/20 0.35
ADRA2C P18825 1/20 0.35
ARG1 P05089 1/20 0.33
ARG2 P78540 1/20 0.33
CACNA2D1 P54289 1/20 0.33
CACNA1B Q00975 1/20 0.33
CACNB1 Q02641 1/20 0.33
ACHE P22303 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22170676 0.85 GBA1 (0.51) GBA1SCN1ASCN4ASCN7AKCNH2
SCHEMBL20343398 0.84 SCN1A (0.56) GBA1SCN1ASCN4ASCN7AKCNH2
SCHEMBL21946389 0.83 GBA1 (0.50) GBA1SCN1ASCN4ASCN7AKCNH2
SCHEMBL20936966 0.80 CHRM5 (0.56) GBA1SCN1ASCN4ASCN7AKCNH2
SCHEMBL23519981 0.80 CHRM5 (0.56) GBA1SCN1ASCN4ASCN7AKCNH2
SCHEMBL20936956 0.80 CHRM5 (0.56) GBA1SCN1ASCN4ASCN7AKCNH2
SCHEMBL21947701 0.80 GBA1 (0.47) GBA1SCN1ASCN4ASCN7AKCNH2
SCHEMBL24319179 0.80 GBA1 (0.47) GBA1SCN1ASCN4ASCN7AKCNH2
SCHEMBL24379284 0.77 GBA1 (0.61) GBA1SCN1ASCN4ASCN7AKCNH2
SCHEMBL21192977 0.77 GBA1 (0.51) GBA1SCN1ASCN4ASCN7AKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021119254-A1 ANTAGONISTS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4 VANDERBILT UNIVERSITY (US) 2021-06-17 WO disclosed